ScopusElsevier Scopus
Status
Active
Coverage
2022–2026
Source type
Journal
Open access
No
CiteScore
2.1
Best quartile
Q3 · 42nd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 104 / 179 | 42nd | Q3 |
| Genetics (clinical) | 77 / 100 | 23rd | Q4 |
Rare Disease and Orphan Drugs Journal
ISSN 2771-2893
Publisher: OAE Publishing Inc.
Scopus · Q3WoS · ESCI
Is Rare Disease and Orphan Drugs Journal indexed in Scopus? Yes — actively indexed in Scopus, coverage 2022–2026, best quartile Q3, CiteScore 2.1.
Is Rare Disease and Orphan Drugs Journal in Web of Science? Yes — indexed in the Emerging Sources Citation Index.
Is Rare Disease and Orphan Drugs Journal open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
2.1
CiteScore 2025
Scopus
Q3
Best quartile
42nd percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.